ArticleSTAR protocols2021
Protocol for determining zinc-dependent β cell-selective small-molecule delivery in mouse pancreas.
Timothy M Horton, Benjamin R Kraemer, Justin P Annes
Open access · goldAbstract read
In one paragraphArticle in STAR protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
3 authors at 1 institution in 1 country.
Timothy M HortonDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA.
Benjamin R KraemerDivision of Endocrinology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Justin P AnnesChemistry, Engineering and Medicine for Human Health (ChEM-H) Institute, Stanford University, Stanford, CA 94305, USA.
Stanford University · US
Funding
Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0MSpectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1MStanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5MThe Role of Adenosine Kinase in Controlling Beta-Cell RegenerationR01DK101530 · NIDDK · STANFORD UNIVERSITY · PI ANNES, JUSTIN PIERCE · 2015 to 2024
$3.8MDevelopment of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug StrategyR01DK119955 · NIDDK · STANFORD UNIVERSITY · PI ANNES, JUSTIN PIERCE · 2019 to 2023
$2.1MStanford Chem-H Chemistry/Biology Interface Predoctoral Training ProgramT32GM120007 · NIGMS · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2020
$1.2MNCATS NIH HHS UL1 TR001085NCATS NIH HHS UL1 TR003142NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK101530NIDDK NIH HHS R01 DK119955NIGMS NIH HHS T32 GM120007
6 · The paper itselfAbstract
Targeted drug delivery to pancreatic islet β cells is an unmet clinical need. β cells possess a uniquely high Zn
Indexed as
Chelating AgentsDrug Delivery SystemsZincAnimalsInsulin-Secreting CellsMiceChelating AgentsZincCell-based assaysCell biologyModel organismsMolecular/chemical probes
Identifiers
PMID33490979
PMCPMC7806521
OpenAlexW3119319254
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390